Abstract:Abstract Background/Aims Autoimmune rheumatic diseases are frequently diagnosed in women of childbearing age. Managing these conditions during pregnancy is complex because commonly used disease-modifying antirheumatic drugs (DMARDs) can pose risks. Specialized care for this patient group is crucial, necessitating adherence to established rheumatology practice standards and British Society for Rheumatology (BSR) guidelines. Our main objective is to review management of childbearing age females with rheumatic diseases attending Basildon hospital as per BSR guidelines. Methods The data for this retrospective study was collected from the electronic records of female patients attending the rheumatology outpatient clinic at Basildon Hospital between September and December 2022. We reviewed age, the specific rheumatological diagnosis, disease duration, disease activity, current medications, and whether general advice or pregnancy-specific advice was provided. Results Out of the initial cohort of 63 female patients, 48 (76%) aged between 18-55 years were selected as women of childbearing age, The median age was 46 years, with 65% in the age groups of 31-50 years, 25% in group 51-55 years and 10% 18-30 years age group. 58% of patients had inflammatory arthritis, 18.7% had connective tissue disease, 18.7% had other conditions such as hypermobility, osteoarthritis, and regional pain syndrome, 2.3% were diagnosed with vasculitis and 2.3% with polymyalgia rheumatica. Breakdown of inflammatory arthritis patients revealed rheumatoid arthritis in 64%, psoriatic arthritis 15% and ankylosing spondylitis 12%. Axial spondyloarthropathy, palindromic rheumatism, and juvenile idiopathic arthritis, each accounted for 3%. Regarding prescribed medications, 66% of the individuals were on conventional DMARDs, biologics 24%, corticosteroids 6% and 4% were on other treatments. The DMARDs prescribed were methotrexate 27%, hydroxychloroquine 19%, sulfasalazine 13%, mycophenolate 3% and leflunomide 1%. The majority of patients had disease activity in remission or mild, each accounting for 23%. Moderate and severe disease activity were reported in 21% each of the audited sample. Patients received advice specifically related to pregnancy 29%, while 71% did not have documented pregnancy-related guidance. 70% of females of reproductive age received general advice. Conclusion The study highlights a gap in pregnancy-related advice among the childbearing age patients as only 29% received guidance on pregnancy. This underpins the need for proactive counselling and education for female patients in routine practice, work in partnership with obstetric teams, and primary care to reduce potential pregnancy related complications and improve outcomes. Disclosure M. Mohareb: None. S. Ahmed: None. A. Bharadwaj: None. A. Nandagudi: None.

Pregnancy and Rheumatic Diseases

Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation

Monitoring and prevention of maternal and infant adverse outcomes in pregnancy women with rheumatic diseases

Safety of Medications Used to Treat Autoimmune Rheumatic Diseases During Pregnancy and Lactation

Rheumatoid Arthritis and Pregnancy: Managing Disease Activity and Fertility Concerns

Medication Strategy for RA Patients During Pregnancy, Perinatal Period and Lactation

[Recommendations for the Medication of Rheumatic Diseases in Periconceptional Period].

State of the art: Reproduction and pregnancy in rheumatic diseases

Fertility and pregnancy in systemic sclerosis and other autoimmune rheumatic diseases

Management of Rheumatic Diseases During Pregnancy and BreastfeedingManagement von rheumatischen Erkrankungen in Schwangerschaft und Stillzeit

Autoimmune diseases and pregnancy

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

Pharmaceutical Care on Two Pregnant Patients with Reumatic Autoimmune Disease Accompanied with Abnormal Liver Function

Rheumatoid arthritis-associated complications during pregnancy and its effect on offspring: comprehensive review

Anemia and iron deficiency in pregnant women with rheumatic diseases

Pregnancy Outcome in Women with Rheumatic Heart Disease

Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients

Reproductive Health in RA, Lupus, and APS

Pregnancy-related issues from the perspective of patients with inflammatory rheumatic diseases – Results from a survey of the members of the National Association for Inflammatory Rheumatic Diseases

Annals of the Rheumatic Diseases collection on pregnancy 2018–2023: observational data-driven knowledge

E008 Review of rheumatology care for women of childbearing age